Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013335.4(GMPPA):c.133G>A(p.Ala45Thr) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
GMPPA (HGNC:22923): (GDP-mannose pyrophosphorylase A) This gene is thought to encode a GDP-mannose pyrophosphorylase. This enzyme catalyzes the reaction which converts mannose-1-phosphate and GTP to GDP-mannose which is involved in the production of N-linked oligosaccharides. [provided by RefSeq, Jul 2008]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.133G>A (p.A45T) alteration is located in exon 3 (coding exon 2) of the GMPPA gene. This alteration results from a G to A substitution at nucleotide position 133, causing the alanine (A) at amino acid position 45 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of glycosylation at A45 (P = 0.0593);Gain of glycosylation at A45 (P = 0.0593);Gain of glycosylation at A45 (P = 0.0593);Gain of glycosylation at A45 (P = 0.0593);Gain of glycosylation at A45 (P = 0.0593);.;Gain of glycosylation at A45 (P = 0.0593);Gain of glycosylation at A45 (P = 0.0593);